IncFact
Company Profiles: Revenue, Growth, Competition

NEUROPHAGE PHARMACEUTICALS Revenue, Growth & Competitor Profile

DBA PROCLARA BIOSCIENCES, INC.
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Neurophage Pharmaceuticals

Access the complete profile.

Neurophage Pharmaceuticals Fast Facts

Revenue$10 - $50 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
Address85 Bolton Street, Suite 212
Cambridge, MA 02140

Note: Revenues for privately held companies are statistical evaluations.


Neurophage Pharmaceuticals's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Neurophage Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Neurophage Pharmaceuticals Annual Revenue and Growth Rate

Neurophage Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Neurophage Pharmaceuticals's revenues are gauged from an analysis of company filings.



Investor Activity

Neurophage Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
November 16, 2018 10 69%$10 MM
Complete list of funding rounds and total amounts in the Company Report




Neurophage Pharmaceuticals's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Neurophage Pharmaceuticals Revenue (Sales) Neurophage Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Neurophage Pharmaceuticals is developing and marketing. Neurophage Pharmaceuticals doesn't have any recent trademark applications, indicating Neurophage Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PROCLARA BIOSCIENCES
Pharmaceutical preparations for use in the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for use in the prevention and treatment of diseases and disorders caused by misfolded protein deposits; pharmaceutical preparations for use in the prevention and treatment of Alzheimer's disease
06/24/2016
NEUROPHAGE
Pharmaceutical compositions for use in the prevention and treatment of diseases and disorders characterized by protein aggregation
03/14/2011

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Neurophage Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Neurophage Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Neurophage Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Neurophage Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
THERADAPTIVELexington, MA46 
BETULA EXTRACTIVESWaconia, MN20 




Nearby Competitors

These companies are similar in business line and location to Neurophage Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ABCAMCambridge, MA100 
BRAINTREE LABORATORIESBraintree, MA74 
MERRIMACK PHARMACEUTICALSCambridge, MA66 
RUBIUS THERAPEUTICSCambridge, MA46 
SERVIER PHARMACEUTICALSBoston, MA37 
FOGHORN THERAPEUTICSCambridge, MA18 




Future Competition: Neurophage Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Neurophage Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Neurophage Pharmaceuticals Competitors